Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.39 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | VNN1 | O95497 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9338162 | 0.82 | AKR1C1 (0.65) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL30475673 | 0.81 | ALDH1A1 (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL17896072 | 0.81 | AKR1C1 (0.62) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL25062470 | 0.81 | ALDH1A1 (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL89653 | 0.81 | OPRM1 (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL27925690 | 0.80 | ALDH1A1 (0.46) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL15823293 | 0.79 | LMNA (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL3664975 | 0.79 | LMNA (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL31091550 | 0.78 | OPRM1 (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 | |
| SCHEMBL15348892 | 0.78 | OPRM1 (0.47) | ALDH1A1AKR1C1P2RX7LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230054997-A1 | COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | ALS THERAPY DEVELOPMENT INSTITUTE, | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230054997-A1 | COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | SOD1, SMN1; SMN2, CLN6 | ALDH1A1 1721/4885AKR1C1 3786/4885P2RX7 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.